The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
Retatrutide is a synthetic multi-agonist peptide designed to interact with GLP-1, GIP, and glucagon receptor pathways. It is investigated in metabolic research examining receptor-mediated signaling cascades and energy-regulation mechanisms.